September 28, 2016 4:47 AM ET

Pharmaceuticals

Company Overview of Sanofi

Executive Profile

Robert Castaigne

Independent Director and Chairman of Audit Committee, Sanofi
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 10 different industries.

See Board Relationships
70€125,000

Background

Mr. Robert Castaigne served as the Chief Financial Officer of TOTAL S.A. from 1994 to June 1, 2008, Officer since 1990 and also served as its Executive Vice President until June 1, 2008. Mr. Castaigne started his career at TOTAL in 1972, where he served as an Engineer since January 1, 1972 and as Departmental Head within the Economic Division until 1977. He served as the Chief Financial Officer of the Total Group until May 2008. He served as the Head of The Exploration-Production ...

Corporate Headquarters

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 42 96

Board Members Memberships

Director
Director and Member of Audit Committee
2000-Present
Independent Director and Chairman of Audit Committee
2007-Present
Independent Director, Chairman of Remuneration Committee and Member of Audit Committee
2009-Present
Independent Director, Member of Audit & Internal Control Committee and Member of Nomination & Corporate Governance Committee
2015-Present
Independent Director, Member of Audit Committee and Member of Compensation & Nomination Committee

Education

Unknown/Other Education
Ecole Nationale Superieur du Petrole et des Moteurs
Unknown/Other Education
Ecole Centrale des Techniques de l'Environnement Industriel
PhD
Universite Paris 1 Pantheon-Sorbonne

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation€125,000
Total Calculated Compensation€125,000
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John F. Milligan Ph.D.Chief Executive Officer, President and Director
Gilead Sciences Inc.
$1.2M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$1.0M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$3.3M
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
$21.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanofi, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.